Drug Profile
Research programme: therapeutics for immunological disorders - Chugai/Osaka University
Latest Information Update: 28 Jun 2020
Price :
$50
*
At a glance
- Originator Chugai Pharmaceutical; Osaka University
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Immunological disorders
Most Recent Events
- 28 Jun 2020 No recent reports of development identified for research development in Immunological-disorders in Japan
- 19 May 2016 Early research in Immunological disorders in Japan (unspecified route)
- 19 May 2016 Chugai and Osaka University Immunology Frontier Research Center enter into research collaboration to develop therapeutics for Immunological disorders